Hyperway Pharmaceuticals logo

Hyperway Pharmaceuticals

A biotech startup focused on small molecule drug discovery

1 employees · est. 2019 · Chengdu, China

VS
NiKang Therapeutics Inc. logo

NiKang Therapeutics Inc.

37 employees · est. 2017 · Wilmington, United States

NiKang Therapeutics Inc. is the older company (2019 vs 2017); NiKang Therapeutics Inc. is the larger of the two.

Side-by-Side Comparison

Hyperway Pharmaceuticals NiKang Therapeutics Inc.
Founded
2019 2017 older
Headquarters
Chengdu, China Wilmington, United States
Employees
1 37 larger
Industry
Health Care, Pharmaceutical Biotechnology, Health Care
Funding Stage
Series A Series C
Total Funding
$100.00M $260.00M
Funding Rounds
3 3
Services
Not tracked yet Innovative Drug Development, Precision Medicine Solutions, Clinical Research
Target Customers
Not tracked yet Oncologists, Pharmaceutical Companies, Cancer Research Institutions, Healthcare Providers
Taxonomy
Pharmaceutical R&D, High-end APIs, Innovation, Research And Development, Small Molecule Drugs, High-Tech Advancements, Global Platform, Drug Development, Management, Fortune 500 Companies, Clinical Trials, Chengdu, Sichuan Province, Domestic Pharmaceutical Companies, Expertise, Generic Medications Not tracked yet
Website
hyperwaypharma.com nikangtx.com
Hyperway Pharmaceuticals logo

About Hyperway Pharmaceuticals

Hyperway Pharm is a pharmaceutical research and production enterprise with a strong focus on innovation and excellence. Founded in 2019, the company is dedicated to pioneering small molecule drugs and high-end APIs with a commitment to technological advancements in the Health Care and Pharmaceutical...

NiKang Therapeutics Inc. logo

About NiKang Therapeutics Inc.

NiKang Therapeutics Inc., founded in 2017, is a dynamic force in the Biotechnology and Health Care sectors. This privately-held company based in the United States is dedicated to pioneering novel small molecule oncology drug discovery. Their primary mission focuses on developing first-in-class and b...

We will tell you when either one moves

BounceWatch watches Hyperway Pharmaceuticals and NiKang Therapeutics Inc. for new funding, fast hiring, new executives and a change of software vendor. When one happens, we email you the same day.

Watch both — free

Funding, hiring, leadership and stack changes at Hyperway Pharmaceutica... and NiKang Therapeutics In... — by email.

Frequently Asked Questions

Hyperway Pharmaceuticals — A biotech startup focused on small molecule drug discovery. NiKang Therapeutics Inc.. Both companies operate in related markets but may differ in funding stage, team size, and product focus.
Hyperway Pharmaceuticals has raised $100.00M while NiKang Therapeutics Inc. has raised $260.00M.
Hyperway Pharmaceuticals and NiKang Therapeutics Inc. operate in overlapping markets and are frequently compared. Track both companies on Bounce Watch to monitor their growth signals in real time.

Compare Hyperway Pharmaceuticals with someone else

Start typing a company name or domain.

Compiled from the BounceWatch company index. We last looked at Hyperway Pharmaceuticals on 12 Sep 2024, and NiKang Therapeutics Inc. on 22 Mar 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.

One analytics cookie (Google Analytics). Cookie Policy